Cost-Effectiveness Modeling of Surgery Plus Adjuvant Endocrine Therapy Versus Primary Endocrine Therapy Alone in UK Women Aged 70 and Over With Early Breast Cancer
Authors:
- Geoffrey R. HolmesGHGeoffrey R. Holmes
- Maria BurtonMBMaria Burton
- Kate LiffordKLKate Lifford
- Adrian EdwardsAEAdrian Edwards
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Value in Health
- Vol. 24 (6) , 770-779
Abstract
No abstract availableKeywords
Funding Information
- National Institute for Health Research
This publication has 31 references indexed in Scilit:
- Are lower rates of surgery amongst older women with breast cancer in the UK explained by co-morbidity?British Journal of Cancer, 2012
- Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curvesBMC Medical Research Methodology, 2012
- Cost-effectiveness of MRI and PET imaging for the evaluation of axillary lymph node metastases in early stage breast cancerEuropean Journal of Surgical Oncology, 2011
- Populating an Economic Model with Health State Utility Values: Moving toward Better PracticeValue in Health, 2010
- Health care costs for the treatment of breast cancer recurrent events: estimates from a UK-based patient-level analysisBritish Journal of Cancer, 2007
- Use and Outcomes of Adjuvant Chemotherapy in Older Women With Breast CancerJournal of Clinical Oncology, 2006
- Flexible parametric proportional‐hazards and proportional‐odds models for censored survival data, with application to prognostic modelling and estimation of treatment effectsStatistics in Medicine, 2002
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- Tamoxifen as initial sole treatment of localised breast cancer in elderly women: a pilot study.BMJ, 1982
- Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily LivingThe Gerontologist, 1969